Showing 1,261 - 1,280 results of 61,004 for search '(( a ((((laser decrease) OR (mean decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 0.84s Refine Results
  1. 1261

    List of excluded studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  2. 1262
  3. 1263
  4. 1264
  5. 1265

    T1R3 KO mice on a Western diet have fewer large adipocytes but increased adipocyte number. by Becky R. Simon (512653)

    Published 2014
    “…B) T1R3 KO animals have decreased frequency of large adipocytes, defined as having a surface area greater than 7500 µm<sup>2</sup>, relative to WT animals. …”
  6. 1266

    Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. <b>a. Western blot analysis:</b> the expression of ERG protein detected by Western blot showed the effects of siRNAs against TMPRSS2-ERG, ERG wild type or siRNA Control. …”
  7. 1267
  8. 1268
  9. 1269
  10. 1270

    ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alo... by Rafael de Montier P. Barroso (10366820)

    Published 2021
    “…After treatment, best-corrected visual acuity was significantly (p<0.05) improved at all follow-up visits in the group receiving intravitreal injection alone, at all but week 4 in the ETDRS group, and at all but weeks 4 and 8 for the PASCAL group. A significant decrease in central subfield macular thickness was observed in the PASCAL group at weeks 4, 8, and 48; only at week 48 in the intravitreal injection group; and never in the ETDRS group. …”
  11. 1271
  12. 1272
  13. 1273
  14. 1274
  15. 1275
  16. 1276

    sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

    Published 2015
    “…When analyzed separately based upon treatment, the decrease in sC5b-9 levels was due to a decrease in patients treated with mycophenolate mofetil (P < 0.001 by linear regression; n = 12 for all time-points). …”
  17. 1277
  18. 1278
  19. 1279
  20. 1280